Gut microbiome regulates inflammation and insulin resistance: a novel therapeutic target to improve insulin sensitivity Semo, D; Reinecke, H; & Godfrey, R; (2024) In: signal transduction and targeted therapy, 2024/35/9(9) Type of Publication: Review (journal)
The Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Empagliflozin Reverses Hyperglycemia-Induced Monocyte and Endothelial Dysfunction Primarily through Glucose Transport… Semo, D; Obergassel, J; Dorenkamp, M; Hemling, P; Strutz, J; Hiden, U; Müller, N; Müller, UA; Zulfikar, SA; Godfrey, R; Waltenberger, J; (2023) In: Journal of Clinical Medicine, 12(4) Type of Publication: Research article (journal)
Pharmacological Targeting of the RAGE-NFκB Signalling Axis Impedes Monocyte Activation under Diabetic Conditions through the Repression of SHP-2 Tyrosine Phosphatase Function Dorenkamp, M; Nasiry, M; Sem,o D; Koch, S; Löffler, I; Wolf, G; Reinecke, H; Godfrey, R (2023) In: Cells, 12(3) Type of Publication: Research article (journal)
mTOR-Dependent Oxidative Stress Regulates oxLDL-Induced Trained Innate Immunity in Human Monocytes Sohrabi, Y; Lagache, SMM; Schnack, L; Godfrey, R; Kahles, F; Bruemmer, D; Waltenberger, J; Findeisen, HM (2019) In: Frontiers in immunology, 9 Type of Publication: Research article (journal)